This contract expires in 233 days (May 3, 2027).
EMORY UNIVERSITY - NIEHS: SERVICE: THIS STUDY WILL EXAMINE NOVEL AND LEGACY PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) IN THE HOPE 1000 STUDY: NON-SEVERABLE
Key Details
Description
NIEHS: SERVICE: THIS STUDY WILL EXAMINE NOVEL AND LEGACY PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) IN THE HOPE 1000 STUDY: NON-SEVERABLE
Context & Analysis
On Aug 3, 2026, Department of Health and Human Services obligated $234,378.06 to EMORY UNIVERSITY for niehs: service: this study will examine novel and legacy per- and polyfluoroalkyl substances (pfas) in the hope 1000 study: non-severable. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: competed under sap with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BETHESDA, MD. The contract is scheduled through May 3, 2027 — approximately 8 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.
Contractor Information
Similar Awards
WASTEWATER SURVEILLANCE TESTING
VERILY HEALTH INC.
$42.3M
INNOVATION FUNNEL FOR COVID-19 - VALIDATION CENTER
EMORY UNIVERSITY
$41.2M
STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
$38.8M
CENTRALIZED OMICS RESOURCE (CORE) YEAR 5
THE BROAD INSTITUTE, INC
$36.4M
NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - TASK AREAS 2, 3, AND 4 - 2024 TASK ORDER
THE BROAD INSTITUTE, INC
$24.5M
Stay Updated
Get notified about new opportunities matching your interests.